| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.5 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |